• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Fujifilm Diosynth Biotechnologies

Fujifilm Diosynth Biotechnologies News

Business

Regeneron and Fujifilm Forge $3B Biotech Alliance to Enhance US Pharmaceutical Production

Michael Lee 23 Apr, 2025

Regeneron Pharmaceuticals Inc. has signed a $3 billion deal with Fujifilm Diosynth Biotechnologies to produce biologic medicines in North Carolina, marking a significant investment...

Popular News

  • Business

    Dramatic Drop in Travel to Azerbaijan and Turkey: MakeMyTrip Reports 60% Decline in Bookings

    14 May, 2025
  • Business

    JetBlue Set to Unveil Strategic US Airline Partnership in Weeks, Expanding Travel Options

    30 Apr, 2025
  • Business

    Apple's Bold Move: In-House Bluetooth and Wi-Fi Chips for Future Devices

    13 Dec, 2024
  • Market

    Dow Surges 500 Points in Premarket as Cooling CPI Data Sparks Market Optimism

    12 Mar, 2025
  • Business

    ASML Reports Staggering 45% Net Sales Growth to €7.7 Billion in Q1 2025

    16 Apr, 2025
  • Business

    Oberoi Group Celebrates 90 Years with Ambitious Skill Development Program

    20 Dec, 2024
  • Business

    Exclusive Stock Market Picks for May 6, 2025: Aurobindo Pharma and IRCTC Lead the Charge

    06 May, 2025
  • Market

    Second Consecutive Session Ends in Red: A Closer Look at the Market's Downturn

    20 Mar, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.